It mentions "Chinese patients" which means that at least generally, cloroquine is not yet used here (Italy) as an accepted/attempted therapeutic protocol (although I'm sure it was used for compassionate use).

Toclizumab is a different story, since there's now a proper trial with 300 patients starting on Thursday.